A Repurposing Pipeline to Candidate‐Suitable Inhibitors of Tyrosinase: Computational and Bioassay Studies
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202401035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Maryam Kabiri und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Graduate Studies, Upstate Medical University, State University of New York, USA. Hauptthemen laut MEDLINE: Monophenol Monooxygenase, Enzyme Inhibitors, Cyclopropanes, Quinolines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Tyrosinase, a metalloprotein enzyme, plays a crucial role in melanin synthesis by hydroxylating L‐tyrosine to L‐dopa. However, the accumulation of melanin can lead to hyperpigmented spots, raising aesthetic concerns. In this study, we developed a pipeline to repurpose FDA‐approved drugs as potential tyrosinase inhibitors. A structure‐based screening study was conducted using 1,650 drugs to identify probable inhibitors based on binding energies. From the cluster analysis of binding interaction profiles, 16 compounds were selected as candidates. Montelukast emerged as the final candidate due to its favorable ADME properties. Bioassay evaluation revealed an IC50 value of 14.79±0.87 μM for Montelukast, compared to kojic acid (IC50=31.02±2.01 μM). Molecular dynamics simulation and g_MMPBSA free energy calculation studies were performed for the Tyrosinase‐Montelukast complex. These findings enhance our understanding of Tyrosinase‐Montelukast interactions and underscore Montelukast's potential as a tyrosinase inhibitor. This could have implications in dermatological applications and beyond, suggesting Montelukast as a promising candidate for further development in this regard.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Graduate Studies, Upstate Medical University, State University of New York, USA.
- Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Science, PO Box 71345-3388, Shiraz, Iran.
- Chair of Bioanalytics, TUM School of Life Sciences, Technische Universität München, Germany.
- Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, PO Box 71345-3388, Shiraz, Iran.
ORCID-Profile: Mohammad Soroosh Hajizade, Mehdi Khoshneviszadeh
Zitieren
APA
Kabiri, M., Hajizade, M. S., Zarei, M., Eskandari, S., Sakhteman, A., & Khoshneviszadeh, M. (2024). A Repurposing Pipeline to Candidate‐Suitable Inhibitors of Tyrosinase: Computational and Bioassay Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401035
Vancouver
Kabiri M, Hajizade MS, Zarei M, Eskandari S, Sakhteman A, Khoshneviszadeh M. A Repurposing Pipeline to Candidate‐Suitable Inhibitors of Tyrosinase: Computational and Bioassay Studies. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401035
BibTeX
@article{Kabiri2024,
author = {Kabiri, Maryam and Hajizade, Mohammad Soroosh and Zarei, Mina and Eskandari, Simin and Sakhteman, Amirhossein and Khoshneviszadeh, Mehdi},
title = {A Repurposing Pipeline to Candidate‐Suitable Inhibitors of Tyrosinase: Computational and Bioassay Studies},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202401035}
}
EUVIMED